Cargando…

Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer

OBJECTIVES: The value of adjuvant radiotherapy for triple‐negative breast cancer (TNBC) has been controversial recently. This study aims to clarify the influence of radiotherapy on the survival of TNBC patients after surgery based on a large population analysis. METHODS: The Surveillance, Epidemiolo...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Yi, Chu, Yuxin, Xu, Bin, Hu, Qinyong, Song, Qibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382720/
https://www.ncbi.nlm.nih.gov/pubmed/30632300
http://dx.doi.org/10.1002/cam4.1954
_version_ 1783396700990210048
author Yao, Yi
Chu, Yuxin
Xu, Bin
Hu, Qinyong
Song, Qibin
author_facet Yao, Yi
Chu, Yuxin
Xu, Bin
Hu, Qinyong
Song, Qibin
author_sort Yao, Yi
collection PubMed
description OBJECTIVES: The value of adjuvant radiotherapy for triple‐negative breast cancer (TNBC) has been controversial recently. This study aims to clarify the influence of radiotherapy on the survival of TNBC patients after surgery based on a large population analysis. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was exploited to select eligible patients from 2010 to 2014. The categorical variables were examined by chi‐square tests. Breast cancer‐specific survival (BCSS) and overall survival (OS) were compared among patients who received or not received adjuvant radiotherapy after surgery by Kaplan‐Meier method with log‐rank test. Univariate and multivariate survival analysis of BCSS and OS were performed using the Cox proportional hazard model. RESULTS: Totally 22 802 patients were enrolled in this study, of which 10 905 patients received radiotherapy after surgery while 11 897 patients did not receive radiotherapy. Compared with those patients who did not receive radiotherapy, the radiation group had a larger proportion of tumor size <2.0 cm (45.8% vs 38.8%) and chemotherapy (82.5% vs 67.4%). The Kaplan‐Meier plots displayed that patients in the radiation group had better survival than the no radiation group in both BCSS and OS (P < 0.001, respectively). In univariate Cox analysis of BCSS, age 40‐60, married status, white and other race, chemotherapy, radiation, and surgery were associated with better survival (HR < 1, P < 0.05). Specifically, patients who received radiotherapy exhibited better BCSS (HR = 0.52, 95% CI = 0.48‐0.57, P < 0.001). After adjusting for confounding factors by multivariable Cox regression analysis, receipt of radiotherapy was still associated with improved BCSS (HR = 0.79, 95% CI = 0.72‐0.87, P < 0.001). Survival analysis of OS produced similar results. Generally, these data indicate that radiotherapy after surgery has significant survival benefits for the TNBC patients. CONCLUSIONS: This study has confirmed the survival advantage of adjuvant radiotherapy for the TNBC patients. These findings may optimize the current individualized treatment decisions for this patient population.
format Online
Article
Text
id pubmed-6382720
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-63827202019-03-01 Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer Yao, Yi Chu, Yuxin Xu, Bin Hu, Qinyong Song, Qibin Cancer Med Clinical Cancer Research OBJECTIVES: The value of adjuvant radiotherapy for triple‐negative breast cancer (TNBC) has been controversial recently. This study aims to clarify the influence of radiotherapy on the survival of TNBC patients after surgery based on a large population analysis. METHODS: The Surveillance, Epidemiology, and End Results (SEER) database was exploited to select eligible patients from 2010 to 2014. The categorical variables were examined by chi‐square tests. Breast cancer‐specific survival (BCSS) and overall survival (OS) were compared among patients who received or not received adjuvant radiotherapy after surgery by Kaplan‐Meier method with log‐rank test. Univariate and multivariate survival analysis of BCSS and OS were performed using the Cox proportional hazard model. RESULTS: Totally 22 802 patients were enrolled in this study, of which 10 905 patients received radiotherapy after surgery while 11 897 patients did not receive radiotherapy. Compared with those patients who did not receive radiotherapy, the radiation group had a larger proportion of tumor size <2.0 cm (45.8% vs 38.8%) and chemotherapy (82.5% vs 67.4%). The Kaplan‐Meier plots displayed that patients in the radiation group had better survival than the no radiation group in both BCSS and OS (P < 0.001, respectively). In univariate Cox analysis of BCSS, age 40‐60, married status, white and other race, chemotherapy, radiation, and surgery were associated with better survival (HR < 1, P < 0.05). Specifically, patients who received radiotherapy exhibited better BCSS (HR = 0.52, 95% CI = 0.48‐0.57, P < 0.001). After adjusting for confounding factors by multivariable Cox regression analysis, receipt of radiotherapy was still associated with improved BCSS (HR = 0.79, 95% CI = 0.72‐0.87, P < 0.001). Survival analysis of OS produced similar results. Generally, these data indicate that radiotherapy after surgery has significant survival benefits for the TNBC patients. CONCLUSIONS: This study has confirmed the survival advantage of adjuvant radiotherapy for the TNBC patients. These findings may optimize the current individualized treatment decisions for this patient population. John Wiley and Sons Inc. 2019-01-10 /pmc/articles/PMC6382720/ /pubmed/30632300 http://dx.doi.org/10.1002/cam4.1954 Text en © 2019 The Authors. Cancer Medicine published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Clinical Cancer Research
Yao, Yi
Chu, Yuxin
Xu, Bin
Hu, Qinyong
Song, Qibin
Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
title Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
title_full Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
title_fullStr Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
title_full_unstemmed Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
title_short Radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
title_sort radiotherapy after surgery has significant survival benefits for patients with triple‐negative breast cancer
topic Clinical Cancer Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382720/
https://www.ncbi.nlm.nih.gov/pubmed/30632300
http://dx.doi.org/10.1002/cam4.1954
work_keys_str_mv AT yaoyi radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer
AT chuyuxin radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer
AT xubin radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer
AT huqinyong radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer
AT songqibin radiotherapyaftersurgeryhassignificantsurvivalbenefitsforpatientswithtriplenegativebreastcancer